These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16366376)

  • 21. Cryoablation for liver cancer.
    Hinshaw JL; Lee FT
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):47-57. PubMed ID: 17980318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous ablation of hepatocellular carcinoma: current status.
    McWilliams JP; Yamamoto S; Raman SS; Loh CT; Lee EW; Liu DM; Kee ST
    J Vasc Interv Radiol; 2010 Aug; 21(8 Suppl):S204-13. PubMed ID: 20656230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies.
    Pearson AS; Izzo F; Fleming RY; Ellis LM; Delrio P; Roh MS; Granchi J; Curley SA
    Am J Surg; 1999 Dec; 178(6):592-9. PubMed ID: 10670879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
    Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How I do it: radiofrequency ablation and cryoablation of lung tumors.
    Sharma A; Moore WH; Lanuti M; Shepard JA
    J Thorac Imaging; 2011 May; 26(2):162-74. PubMed ID: 21508737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation of hepatic tumors: lessons learned from 3000 procedures.
    Rhim H; Lim HK; Kim YS; Choi D; Lee WJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1492-500. PubMed ID: 18713294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radiofrequency ablation of malignant liver tumours].
    Drug VL; Bugioeanu C; Burcoveanu C; Balan G; Prelipcean CC; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):23-31. PubMed ID: 19292074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
    Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K
    AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
    Amersi FF; McElrath-Garza A; Ahmad A; Zogakis T; Allegra DP; Krasne R; Bilchik AJ
    Arch Surg; 2006 Jun; 141(6):581-7; discussion 587-8. PubMed ID: 16785359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria--a comparative study.
    Lai EC; Tang CN
    Int J Surg; 2013; 11(1):77-80. PubMed ID: 23220487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency ablation for malignant liver tumor.
    Ng KK; Poon RT
    Surg Oncol; 2005 Jul; 14(1):41-52. PubMed ID: 15777889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial ablative techniques for hepatic tumours.
    Erce C; Parks RW
    Br J Surg; 2003 Mar; 90(3):272-89. PubMed ID: 12594662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes after hepatic resection combined with radiofrequency ablation for initially unresectable multiple and bilobar liver malignancies.
    Qiu J; Chen S; Wu H
    J Surg Res; 2014 May; 188(1):14-20. PubMed ID: 24387841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.
    Ho CM; Lee PH; Shau WY; Ho MC; Wu YM; Hu RH
    Surgery; 2012 May; 151(5):700-9. PubMed ID: 22284764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency ablation of liver cancer.
    Lencioni R; Crocetti L
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):38-46. PubMed ID: 17980317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
    Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
    Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of liver resection in combination with radiofrequency ablation for hepatic malignancies.
    Eisele RM; Zhukowa J; Chopra S; Schmidt SC; Neumann U; Pratschke J; Schumacher G
    Eur J Surg Oncol; 2010 Mar; 36(3):269-74. PubMed ID: 19726155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation.
    Yang B; Zou J; Xia J; Ren Z; Gan Y; Wang Y; Zhang B; Ge N; Wang D; Chen Y; Chen R; Li L; Ye S; Wang X
    Eur J Radiol; 2011 Aug; 79(2):196-200. PubMed ID: 20303686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.